185 related articles for article (PubMed ID: 1323368)
1. Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study.
Walker JM; Bowen WD; Goldstein SR; Roberts AH; Patrick SL; Hohmann AG; DeCosta B
Brain Res; 1992 May; 581(1):33-8. PubMed ID: 1323368
[TBL] [Abstract][Full Text] [Related]
2. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes.
Bouchard P; Quirion R
Neuroscience; 1997 Jan; 76(2):467-77. PubMed ID: 9015331
[TBL] [Abstract][Full Text] [Related]
3. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
[TBL] [Abstract][Full Text] [Related]
4. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
Nguyen VH; Kassiou M; Johnston GA; Christie MJ
Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
[TBL] [Abstract][Full Text] [Related]
5. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain.
Hellewell SB; Bowen WD
Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic identification and characterization of sigma receptors in guinea pig brain using [3H]1(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'-oxoethyl) piperidine ([3H]DuP 734), a novel sigma receptor ligand.
Heroux JA; Tam SW; De Souza EB
Brain Res; 1992 Dec; 598(1-2):76-86. PubMed ID: 1486505
[TBL] [Abstract][Full Text] [Related]
7. NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain.
Chaki S; Tanaka M; Muramatsu M; Otomo S
Eur J Pharmacol; 1994 Jan; 251(1):R1-2. PubMed ID: 8137864
[TBL] [Abstract][Full Text] [Related]
8. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
9. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
Karbon EW; Naper K; Pontecorvo MJ
Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic characterization of binding sites for [3H]NE-100 in guinea pig brain.
Okuyama S; Chaki S; Yae T; Nakazato A; Muramatsu M
Life Sci; 1995; 57(21):PL333-7. PubMed ID: 7475936
[TBL] [Abstract][Full Text] [Related]
11. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
Brent PJ
Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
[TBL] [Abstract][Full Text] [Related]
12. Regional variation in the ratio of sigma 1 to sigma 2 binding in rat brain.
Leitner ML; Hohmann AG; Patrick SL; Walker JM
Eur J Pharmacol; 1994 Jun; 259(1):65-9. PubMed ID: 7957595
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors.
de Costa BR; Bowen WD; Hellewell SB; Walker JM; Thurkauf A; Jacobson AE; Rice KC
FEBS Lett; 1989 Jul; 251(1-2):53-8. PubMed ID: 2568952
[TBL] [Abstract][Full Text] [Related]
14. Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain.
DeHaven-Hudkins DL; Fleissner LC
Life Sci; 1992; 50(9):PL65-70. PubMed ID: 1346920
[TBL] [Abstract][Full Text] [Related]
15. Binding of dexetimide and levetimide to [3H](+)pentazocine- and [3H]1,3-di(2-tolyl)guanidine-defined sigma recognition sites.
DeHaven-Hudkins DL; Hudkins RL
Life Sci; 1991; 49(18):PL135-9. PubMed ID: 1656155
[TBL] [Abstract][Full Text] [Related]
16. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.
Weber E; Sonders M; Quarum M; McLean S; Pou S; Keana JF
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8784-8. PubMed ID: 2877462
[TBL] [Abstract][Full Text] [Related]
17. Discrepancies in characterization of sigma sites in the mouse central nervous system.
Kovács KJ; Larson AA
Eur J Pharmacol; 1995 Oct; 285(2):127-34. PubMed ID: 8566130
[TBL] [Abstract][Full Text] [Related]
18. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
Rothman RB; Reid A; Mahboubi A; Kim CH; De Costa BR; Jacobson AE; Rice KC
Mol Pharmacol; 1991 Feb; 39(2):222-32. PubMed ID: 1847495
[TBL] [Abstract][Full Text] [Related]
19. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
20. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain.
Codd EE; Shank RP
Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]